Drug Discovery and Development Services At Porsolt, our commitment goes beyond providing drug discovery services – it's about enabling significant advancements in medical research. Supported by a team of experienced scientists…
Porsolt is thrilled to have another paper published in oncology: “A Face-To-Face Comparison of Tumor Chicken Chorioallantoic Membrane (TCAM) In Ovo with Murine Models for Early Evaluation of Cancer Therapy…
Porsolt, GlioCure, and CHU d'Angers have joined forces in the “Glio Preclinical Solutions (GPS)” collaborative project to develop new and innovative models for the evaluation of first- and best-in class…
We recently validated two novel reference compounds in our Electrical Amygdala Kindling in vivo model: Retigabine and Perampanel (third generation drug), in keeping up with the most recent clinical developments and the…
Porsolt collaborates with academic institutions to enhance research programs that benefit industry and academia alike. We are excited to share a recently published review paper entitled "Memory Disorders Related to…